Compare GGT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GGT | DERM |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.5M | 135.3M |
| IPO Year | N/A | 2021 |
| Metric | GGT | DERM |
|---|---|---|
| Price | $4.34 | $6.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | ★ 286.7K | 264.5K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | N/A | ★ 34.72 |
| EPS | ★ 0.83 | N/A |
| Revenue | N/A | ★ $61,858,000.00 |
| Revenue This Year | N/A | $39.72 |
| Revenue Next Year | N/A | $63.24 |
| P/E Ratio | $5.18 | ★ N/A |
| Revenue Growth | N/A | ★ 10.20 |
| 52 Week Low | $3.75 | $4.31 |
| 52 Week High | $4.39 | $9.56 |
| Indicator | GGT | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 61.13 | 52.36 |
| Support Level | $4.11 | $5.77 |
| Resistance Level | $4.37 | $7.66 |
| Average True Range (ATR) | 0.06 | 0.41 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 83.33 | 54.91 |
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.